Cerebral Microbleeds and Risk of Intracerebral Hemorrhage Post Intravenous Thrombolysis.

Background: Stroke patients who have cerebral micro bleeds (CMBs) could be potentially at a greater risk for symptomatic intracerebral hemorrhage (sICH) than those patients without CMBs. The aim of our study was to investigate whether the presence and burden of CMBs are associated with post IVT sICH...

Full description

Bibliographic Details
Published in:Journal of Stroke & Cerebrovascular Diseases Vol. 26; no. 3; pp. 538 - 545
Main Authors: Zand, Ramin, Tsivgoulis, Georgios, Singh, Mantinderpreet, McCormack, Michael, Goyal, Nitin, Ishfaq, Muhammad Fawad, Shahripour, Reza Bavarsad, Nearing, Katherine, Elijovich, Lucas, Alexandrov, Anne W., Liebeskind, David S., Alexandrov, Andrei V.
Format: research Journal Article
Published: W B Saunders Mar2017
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=121259676&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 121259676
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10523057
        DOU
      jtl: Journal of Stroke & Cerebrovascular Diseases
      issn: 10523057
      maglogo: N
    pubinfo:
      dt: Mar2017
      vid: 26
      iid: 3
      pid: 1351
      pub: W B Saunders
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        121259676
        121259676
        NLM28065404
        121259676
        10.1016/j.jstrokecerebrovasdis.2016.11.127
        NLM28065404
        121259676
      ppf: 538
      ppct: 7
      formats:
      tig:
        atl: Cerebral Microbleeds and Risk of Intracerebral Hemorrhage Post Intravenous Thrombolysis.
      aug:
        au:
          Zand, Ramin
          Tsivgoulis, Georgios
          Singh, Mantinderpreet
          McCormack, Michael
          Goyal, Nitin
          Ishfaq, Muhammad Fawad
          Shahripour, Reza Bavarsad
          Nearing, Katherine
          Elijovich, Lucas
          Alexandrov, Anne W.
          Liebeskind, David S.
          Alexandrov, Andrei V.
        affil: Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee
      sug:
        subj:
          Fibrinolytic Agents Adverse Effects
          Tissue Plasminogen Activator Adverse Effects
          Cerebral Hemorrhage Chemically Induced
          Aged, 80 and Over
          Administration, Intravenous Adverse Effects
          Human
          Stroke Drug Therapy
          Prospective Studies
          Aged
          Middle Age
          Cerebral Hemorrhage
          Magnetic Resonance Imaging
          Female
          Male
          Equipment and Supplies
          Adult
          Validation Studies
          Comparative Studies
          Evaluation Research
          Multicenter Studies
          NIH Stroke Scale
          Scales
          Aged, 80 & over
          Aged: 65+ years
          Middle Aged: 45-64 years
          Adult: 19-44 years
          Female
          Male
      ab: Background: Stroke patients who have cerebral micro bleeds (CMBs) could be potentially at a greater risk for symptomatic intracerebral hemorrhage (sICH) than those patients without CMBs. The aim of our study was to investigate whether the presence and burden of CMBs are associated with post IVT sICH.Methods: In this multicenter study, consecutive patients treated with intravenous tissue plasminogen activator were prospectively identified and analyzed. Patients without magnetic resonance imaging (MRI) within 24 hours of treatment were excluded. CMBs were defined as round or oval, hypointense lesions with associated blooming on T2*-weighted MRI up to 10 mm in diameter. Outcome measures included the occurrence of sICH or death.Results: Of 672 patients with IVT (mean age 62 ± 14 years, 52% men, median admission NIHSS: 7 points), 103 patients had CMBs on T2*-MRI. Ten patients had more than 10, whereas the remaining 93 patients had 1-10 CMBs on T2*-MRI. The rates of sICH did not differ between patients with and patients without 1-10 CMBs (5.8% versus 3.5%; P = .27). However, sICH occurred more frequently (P = .0009) in patients with > 10 CMBs (30%, 95% confidence interval [CI] by the adjusted Wald method: 10%-61%). After adjusting for potential confounders, the presence of >10 CMBs on T2*-MRI was independently (P = .0004) associated with a higher likelihood for sICH (odds ratio [OR]:13.4, 95%CI:3.2-55.9).Conclusions: Our findings indicate an increased risk of sICH after IVT when more than 10 CMBs are present.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N